Preventable strokes and deaths in atrial fibrillation patients: Understanding the impacts of anticoagulant nonadherence and nonpersistence
房颤患者可预防的中风和死亡:了解抗凝药物不依从和不坚持的影响
基本信息
- 批准号:410174
- 负责人:
- 金额:$ 18.95万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Operating Grants
- 财政年份:2019
- 资助国家:加拿大
- 起止时间:2019-09-01 至 2022-09-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Atrial fibrillation (Afib) is a type of irregular heart rhythm that is common in Canada. Patients with Afib are at much higher risk of stroke than those without Afib. Stroke can lead to disability or death, so it is crucial to prevent it in those at risk.
心房颤动(Afib)是一种在加拿大常见的不规则心律。房颤患者发生中风的风险比没有房颤的患者高得多。中风可能导致残疾或死亡,因此预防风险人群的中风至关重要。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Loewen Peter S其他文献
Loewen Peter S的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Loewen Peter S', 18)}}的其他基金
Atrial fibrillation stroke prevention: New insights from anticoagulant adherence thresholds and trajectories
房颤卒中预防:抗凝药物依从阈值和轨迹的新见解
- 批准号:
462408 - 财政年份:2022
- 资助金额:
$ 18.95万 - 项目类别:
Operating Grants
相似海外基金
2/2 REACT-AF: Rhythm Evaluation for AntiCoagulaTion with Continuous Monitoring of Atrial Fibrillation
2/2 REACT-AF:通过连续监测心房颤动进行抗凝心律评估
- 批准号:
10509053 - 财政年份:2022
- 资助金额:
$ 18.95万 - 项目类别:
Effectiveness and Safety of Transcatheter Left Atrial Appendage Occlusion vs. Anticoagulation in Older Adults with Atrial Fibrillation and Alzheimer's Disease and Related dementias
经导管左心耳封堵术与抗凝治疗对患有心房颤动、阿尔茨海默病及相关痴呆症的老年人的有效性和安全性
- 批准号:
10672458 - 财政年份:2022
- 资助金额:
$ 18.95万 - 项目类别:
The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF)
心房颤动连续监测试验的抗凝节律评估 (REACT-AF)
- 批准号:
10509310 - 财政年份:2022
- 资助金额:
$ 18.95万 - 项目类别:
The Rhythm Evaluation for Anticoagulation with Continuous Monitoring of Atrial Fibrillation Trial (REACT-AF)
心房颤动连续监测试验的抗凝节律评估 (REACT-AF)
- 批准号:
10725186 - 财政年份:2022
- 资助金额:
$ 18.95万 - 项目类别:
Effectiveness and Safety of Transcatheter Left Atrial Appendage Occlusion vs. Anticoagulation in Older Adults with Atrial Fibrillation and Alzheimer's Disease and Related dementias
经导管左心耳封堵术与抗凝治疗对患有心房颤动、阿尔茨海默病及相关痴呆症的老年人的有效性和安全性
- 批准号:
10443345 - 财政年份:2022
- 资助金额:
$ 18.95万 - 项目类别:
Anticoagulation Therapy Timing in Atrial Fibrillation after Chronic Subdural Hematoma External Drainage(the ATTACHED RCT)
慢性硬膜下血肿外引流术后心房颤动的抗凝治疗时机(附随机对照试验)
- 批准号:
443046 - 财政年份:2021
- 资助金额:
$ 18.95万 - 项目类别:
Operating Grants
The "Atrial FIBrillation in Pregnancy: assessing seveRe matErnal morbidity and anticoagulation strateGies" (AFIB-PREG) Study
“妊娠期心房颤动:评估严重孕产妇发病率和抗凝策略”(AFIB-PREG) 研究
- 批准号:
444740 - 财政年份:2021
- 资助金额:
$ 18.95万 - 项目类别:
Operating Grants
Shared Decision-Making to Reduce Racial Disparities in Oral Anticoagulation Use in Patients with Non-Valvular Atrial Fibrillation
共同决策以减少非瓣膜性心房颤动患者口服抗凝药使用中的种族差异
- 批准号:
10471407 - 财政年份:2021
- 资助金额:
$ 18.95万 - 项目类别:
Shared Decision-Making to Reduce Racial Disparities in Oral Anticoagulation Use in Patients with Non-Valvular Atrial Fibrillation
共同决策以减少非瓣膜性心房颤动患者口服抗凝药使用中的种族差异
- 批准号:
10282856 - 财政年份:2021
- 资助金额:
$ 18.95万 - 项目类别:
Anticoagulation for stroke prevention in patients with recent episodes of perioperative atrial fibrillation after noncardiac surgery - The ASPIRE-AF study
非心脏手术后近期发生围手术期心房颤动的患者抗凝预防中风 - ASPIRE-AF 研究
- 批准号:
444394 - 财政年份:2021
- 资助金额:
$ 18.95万 - 项目类别:
Operating Grants